ミズホメディーの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/02/27 | 3,320 | 3,320 | 3,240 | 3,240 | -105 | -3.1% | 142,100 |
2024/02/26 | 3,355 | 3,375 | 3,325 | 3,345 | ±0 | ±0% | 48,600 |
2024/02/22 | 3,375 | 3,385 | 3,335 | 3,345 | -30 | -0.9% | 58,000 |
2024/02/21 | 3,400 | 3,405 | 3,360 | 3,375 | -30 | -0.9% | 37,100 |
2024/02/20 | 3,450 | 3,470 | 3,385 | 3,405 | -40 | -1.2% | 58,100 |
2024/02/19 | 3,380 | 3,450 | 3,380 | 3,445 | +70 | +2.1% | 46,100 |
2024/02/16 | 3,370 | 3,420 | 3,340 | 3,375 | +30 | +0.9% | 80,400 |
2024/02/15 | 3,400 | 3,430 | 3,315 | 3,345 | -105 | -3% | 163,000 |
2024/02/14 | 3,565 | 3,620 | 3,435 | 3,450 | -130 | -3.6% | 171,400 |
2024/02/13 | 3,645 | 3,750 | 3,475 | 3,580 | -235 | -6.2% | 393,100 |
2024/02/09 | 3,390 | 3,820 | 3,355 | 3,815 | +390 | +11.4% | 942,500 |
2024/02/08 | 3,395 | 3,445 | 3,345 | 3,425 | +70 | +2.1% | 165,100 |
2024/02/07 | 3,375 | 3,380 | 3,325 | 3,355 | -20 | -0.6% | 116,300 |
2024/02/06 | 3,395 | 3,405 | 3,375 | 3,375 | -25 | -0.7% | 97,000 |
2024/02/05 | 3,455 | 3,460 | 3,370 | 3,400 | -55 | -1.6% | 145,400 |
2024/02/02 | 3,480 | 3,485 | 3,440 | 3,455 | -5 | -0.1% | 60,100 |
2024/02/01 | 3,500 | 3,500 | 3,435 | 3,460 | -40 | -1.1% | 80,700 |
2024/01/31 | 3,510 | 3,515 | 3,455 | 3,500 | -10 | -0.3% | 82,700 |
2024/01/30 | 3,520 | 3,570 | 3,510 | 3,510 | ±0 | ±0% | 80,200 |
2024/01/29 | 3,485 | 3,520 | 3,480 | 3,510 | +45 | +1.3% | 66,900 |
2024/01/26 | 3,500 | 3,500 | 3,455 | 3,465 | -30 | -0.9% | 84,500 |
2024/01/25 | 3,500 | 3,505 | 3,485 | 3,495 | -25 | -0.7% | 55,100 |
2024/01/24 | 3,510 | 3,525 | 3,480 | 3,520 | -5 | -0.1% | 83,300 |
2024/01/23 | 3,545 | 3,565 | 3,520 | 3,525 | -15 | -0.4% | 71,100 |
2024/01/22 | 3,565 | 3,580 | 3,515 | 3,540 | -15 | -0.4% | 88,900 |
2024/01/19 | 3,530 | 3,560 | 3,510 | 3,555 | +35 | +1% | 79,100 |
2024/01/18 | 3,505 | 3,545 | 3,460 | 3,520 | +5 | +0.1% | 97,000 |
2024/01/17 | 3,545 | 3,550 | 3,510 | 3,515 | +10 | +0.3% | 89,800 |
2024/01/16 | 3,505 | 3,565 | 3,490 | 3,505 | -5 | -0.1% | 129,600 |
2024/01/15 | 3,445 | 3,510 | 3,440 | 3,510 | +55 | +1.6% | 94,100 |
2024/01/12 | 3,495 | 3,550 | 3,440 | 3,455 | -25 | -0.7% | 142,900 |
2024/01/11 | 3,500 | 3,500 | 3,445 | 3,480 | ±0 | ±0% | 122,000 |
2024/01/10 | 3,490 | 3,515 | 3,460 | 3,480 | ±0 | ±0% | 147,800 |
2024/01/09 | 3,310 | 3,480 | 3,300 | 3,480 | +205 | +6.3% | 209,700 |
2024/01/05 | 3,250 | 3,305 | 3,245 | 3,275 | +25 | +0.8% | 121,700 |
2024/01/04 | 3,120 | 3,260 | 3,105 | 3,250 | +110 | +3.5% | 210,200 |
2023/12/29 | 3,070 | 3,180 | 3,060 | 3,140 | +10 | +0.3% | 269,500 |
2023/12/28 | 3,205 | 3,250 | 3,115 | 3,130 | -415 | -11.7% | 474,700 |
2023/12/27 | 3,485 | 3,550 | 3,450 | 3,545 | +60 | +1.7% | 292,800 |
2023/12/26 | 3,495 | 3,500 | 3,415 | 3,485 | -45 | -1.3% | 310,900 |
2023/12/25 | 3,665 | 3,665 | 3,515 | 3,530 | -130 | -3.6% | 293,900 |
2023/12/22 | 3,660 | 3,680 | 3,620 | 3,660 | +15 | +0.4% | 97,400 |
2023/12/21 | 3,640 | 3,685 | 3,605 | 3,645 | -10 | -0.3% | 128,700 |
2023/12/20 | 3,635 | 3,665 | 3,610 | 3,655 | +25 | +0.7% | 109,300 |
2023/12/19 | 3,610 | 3,650 | 3,595 | 3,630 | +35 | +1% | 90,800 |
2023/12/18 | 3,595 | 3,655 | 3,580 | 3,595 | -5 | -0.1% | 114,000 |
2023/12/15 | 3,660 | 3,675 | 3,580 | 3,600 | -90 | -2.4% | 196,200 |
2023/12/14 | 3,730 | 3,740 | 3,670 | 3,690 | -20 | -0.5% | 98,400 |
2023/12/13 | 3,740 | 3,755 | 3,690 | 3,710 | +35 | +1% | 80,400 |
2023/12/12 | 3,695 | 3,730 | 3,670 | 3,675 | -5 | -0.1% | 102,000 |
51~
100
件表示中 / 2050件
類似銘柄と比較する
現在ご覧いただいている「ミズホメディ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ミズホメディ | 346,500円 | -5.1% | -21.2% | 4.62% | 10.94倍 | 2.11倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
ダイト | 245,600円 | +5.3% | -7.1% | 2.44% | 11.47倍 | 0.73倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック(後発医薬品)メーカー向け強い |
富士製薬 | 154,400円 | +12.7% | +1.8% | 2.75% | 6.07倍 | 0.85倍 |
|
女性医療、急性期医療の2領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
サンバイオ | 41,900円 | - | - | 0.00% | - | 11.12倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
セルソース | 143,700円 | +19.0% | -13.1% | 0.35% | 39.59倍 | 4.63倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
市場注目の銘柄
チャート関連のコラム